<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_dwd8wwG">Association between alcohol consumption and subclinical femoral atherosclerosis in smoking and non-smoking men: the AWHS study</title>
				<funder ref="#_dgdfEKu">
					<orgName type="full">European Regional Development Fund</orgName>
					<orgName type="abbreviated">ESRR</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100008530</idno>
				</funder>
				<funder ref="#_EvDQmme #_Wc6yAJ8">
					<orgName type="full">CIBERCV</orgName>
				</funder>
				<funder>
					<orgName type="full">Instituto de Salud Carlos III</orgName>
					<orgName type="abbreviated">ISCIII</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100004587</idno>
				</funder>
				<funder>
					<orgName type="full">Agencia Aragonesa para la Investigación y el Desarrollo (ARAID)</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Belén</forename><surname>Moreno-Franco</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Universidad de Zaragoza , Zaragoza , Spain , Instituto de Investigación Sanitaria Aragón ,</note>
								<orgName type="department">Instituto de Investigación Sanitaria Aragón</orgName>
								<orgName type="institution">Universidad de Zaragoza</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Hospital Universitario Miguel Servet , CIBERCV , Zaragoza , Spain , Department of Preventive Medicine and Public Health. School of Medicine ,</note>
								<orgName type="department">Department of Preventive Medicine and Public Health. School of Medicine</orgName>
								<orgName type="institution">Hospital Universitario Miguel Servet</orgName>
								<address>
									<addrLine>CIBERCV</addrLine>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alejandro</forename><surname>Pérez-Esteban</surname></persName>
							<idno type="ORCID">0000-0003-0604-5042</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Universidad de Zaragoza , Zaragoza , Spain , Instituto de Investigación Sanitaria Aragón ,</note>
								<orgName type="department">Instituto de Investigación Sanitaria Aragón</orgName>
								<orgName type="institution">Universidad de Zaragoza</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fernando</forename><surname>Civeira</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Universidad de Zaragoza , Zaragoza , Spain , Instituto de Investigación Sanitaria Aragón ,</note>
								<orgName type="department">Instituto de Investigación Sanitaria Aragón</orgName>
								<orgName type="institution">Universidad de Zaragoza</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Hospital Universitario Miguel Servet , CIBERCV , Zaragoza , Spain , Department of Preventive Medicine and Public Health. School of Medicine ,</note>
								<orgName type="department">Department of Preventive Medicine and Public Health. School of Medicine</orgName>
								<orgName type="institution">Hospital Universitario Miguel Servet</orgName>
								<address>
									<addrLine>CIBERCV</addrLine>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Pilar</forename><surname>Guallar-Castillón</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Universidad Autónoma de Madrid-IdiPaz , CIBERESP , Madrid , Spain ,</note>
								<orgName type="institution">Universidad Autónoma de Madrid-IdiPaz</orgName>
								<address>
									<addrLine>CIBERESP</addrLine>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> IMDEA-Food Institute. CEI UAM +CSIC , Madrid , Spain and</note>
								<orgName type="institution">IMDEA-Food Institute. CEI UAM +CSIC</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">José</forename><forename type="middle">Antonio</forename><surname>Casasnovas</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Universidad de Zaragoza , Zaragoza , Spain , Instituto de Investigación Sanitaria Aragón ,</note>
								<orgName type="department">Instituto de Investigación Sanitaria Aragón</orgName>
								<orgName type="institution">Universidad de Zaragoza</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Hospital Universitario Miguel Servet , CIBERCV , Zaragoza , Spain , Department of Preventive Medicine and Public Health. School of Medicine ,</note>
								<orgName type="department">Department of Preventive Medicine and Public Health. School of Medicine</orgName>
								<orgName type="institution">Hospital Universitario Miguel Servet</orgName>
								<address>
									<addrLine>CIBERCV</addrLine>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rocío</forename><surname>Mateo-Gállego</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Universidad de Zaragoza , Zaragoza , Spain , Instituto de Investigación Sanitaria Aragón ,</note>
								<orgName type="department">Instituto de Investigación Sanitaria Aragón</orgName>
								<orgName type="institution">Universidad de Zaragoza</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Hospital Universitario Miguel Servet , CIBERCV , Zaragoza , Spain , Department of Preventive Medicine and Public Health. School of Medicine ,</note>
								<orgName type="department">Department of Preventive Medicine and Public Health. School of Medicine</orgName>
								<orgName type="institution">Hospital Universitario Miguel Servet</orgName>
								<address>
									<addrLine>CIBERCV</addrLine>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Estíbaliz</forename><surname>Jarauta</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Universidad de Zaragoza , Zaragoza , Spain , Instituto de Investigación Sanitaria Aragón ,</note>
								<orgName type="department">Instituto de Investigación Sanitaria Aragón</orgName>
								<orgName type="institution">Universidad de Zaragoza</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Hospital Universitario Miguel Servet , CIBERCV , Zaragoza , Spain , Department of Preventive Medicine and Public Health. School of Medicine ,</note>
								<orgName type="department">Department of Preventive Medicine and Public Health. School of Medicine</orgName>
								<orgName type="institution">Hospital Universitario Miguel Servet</orgName>
								<address>
									<addrLine>CIBERCV</addrLine>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sara</forename><surname>Malo</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Universidad de Zaragoza , Zaragoza , Spain , Instituto de Investigación Sanitaria Aragón ,</note>
								<orgName type="department">Instituto de Investigación Sanitaria Aragón</orgName>
								<orgName type="institution">Universidad de Zaragoza</orgName>
								<address>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>Dr</roleName><forename type="first">Martín</forename><surname>Laclaustra</surname></persName>
							<email>martin.laclaustra@unizar.es</email>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Hospital Universitario Miguel Servet , CIBERCV , Zaragoza , Spain , Department of Preventive Medicine and Public Health. School of Medicine ,</note>
								<orgName type="department">Department of Preventive Medicine and Public Health. School of Medicine</orgName>
								<orgName type="institution">Hospital Universitario Miguel Servet</orgName>
								<address>
									<addrLine>CIBERCV</addrLine>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<note type="raw_affiliation">Agencia Aragonesa para la Investigación y el Desarrollo , ARAID , Zaragoza , Spain Instituto de Investigación Sanitaria Aragón ,</note>
								<orgName type="department">Instituto de Investigación Sanitaria Aragón</orgName>
								<orgName type="institution">Agencia Aragonesa para la Investigación y el Desarrollo</orgName>
								<address>
									<settlement>ARAID Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<note type="raw_affiliation">Hospital Universitario Miguel Servet , Paseo Isabel La Católica 1-3 , 50009 Zaragoza , Spain.</note>
								<orgName type="institution">Hospital Universitario Miguel Servet</orgName>
								<address>
									<addrLine>Paseo Isabel La Católica 1-3</addrLine>
									<postCode>50009</postCode>
									<settlement>Zaragoza</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_p6SnEdc">Association between alcohol consumption and subclinical femoral atherosclerosis in smoking and non-smoking men: the AWHS study</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">891B4FDD0C54AD75D864A0FF8B8ACF51</idno>
					<idno type="DOI">10.1111/add.15012</idno>
					<note type="submission">Submitted 27 June 2019; initial review completed 23 September 2019; final version accepted 11 February 2020</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T14:00+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_JmFDqbA">Alcohol</term>
					<term xml:id="_vHCyfkM">antagonism</term>
					<term xml:id="_BkJrzzx">atherosclerosis</term>
					<term xml:id="_qf6NrNr">cardiovascular disease</term>
					<term xml:id="_YD2v878">smoking</term>
					<term xml:id="_7K2y7zq">risk factors</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_UrGHgBW"><p xml:id="_tedyR6n"><s xml:id="_DPVvHUt">Background and Aims Many addictive substances, such as tobacco and alcohol, influence atherosclerosis development.</s></p><p xml:id="_8NZ5mPR"><s xml:id="_qAHHdNx">Whether or not tobacco's pro-atherosclerotic effect is influenced by alcohol consumption is unknown.</s><s xml:id="_xZKEmPg">We aimed to estimate the impact of alcohol intake on the presence of subclinical atherosclerosis in femoral arteries in smoking and non-smoking middle-aged men.</s><s xml:id="_McH4dNe">Design, Setting and Participants Cross-sectional analysis of a subset of the Aragon Workers Health Study (AWHS), comprising 2099 men with mean age 50.9 years without previous cardiovascular disease.</s></p><p xml:id="_MBk6Zgu"><s xml:id="_zn7W4W5">Measurements The presence of plaques in femoral arteries was assessed by high-resolution sonography.</s><s xml:id="_JkMcE2S">Self-reported alcohol consumption over the previous year was measured with a food frequency questionnaire.</s><s xml:id="_EThUdeu">The sample was divided into four groups according to their daily grams of alcohol consumption ≤ 1 (abstainers), ≥ 2 to &lt; 30, ≥ 30 to &lt; 60 and ≥ 60 g/day.</s><s xml:id="_NyZBFwq">Participants were divided on ever-smoking (current and former) versus never-smoking strata in the main analysis.</s><s xml:id="_fpvwQ8m">Findings We did not find a significant association between the different levels of alcohol intake and the likelihood of developing femoral artery atherosclerosis in never-smokers.</s><s xml:id="_fHzrqK5">Ever-smoking was positively associated with femoral atherosclerosis overall [odds ratio (OR) = 3.00; 95% confidence interval (CI) = 2.40, 3.74; P &lt; 0.001] and within each level of alcohol consumption.</s><s xml:id="_DgCa7jV">Atherosclerosis was lower in ever-smokers who consumed 2 g/day or more but less than 30 g/day with respect to those ever-smokers who were abstainers (OR = 0.70; 95% CI = 0.49, 0.99; P &lt; 0.05).</s><s xml:id="_wKcs7gP">However, among these ever-smokers, atherosclerosis prevalence was still higher than among never-smokers who consumed alcohol in the same amount (2 g/day or more but less than 30 g/day) (OR = 2.73; 95% CI = 2.07, 3.61; P &lt; 0.001).</s></p><p xml:id="_sGQ6KU2"><s xml:id="_q9mjMAM">Conclusions Among middle-aged men, moderate alcohol consumption appears to be associated with lower prevalence of femoral artery subclinical atherosclerosis compared with alcohol abstinence only in ever-smokers.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="593.972" lry="782.986"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jzKyhBW">INTRODUCTION</head><p xml:id="_7V5Cwaf"><s xml:id="_pqfXePM">Atherosclerosis is the pathological process that causes most cardiovascular disease (CVD).</s><s xml:id="_HXfvFVT">Consumption of some addictive substances, such as smoking tobacco and drinking beverages with alcohol, influences its development, even below addiction thresholds.</s></p><p xml:id="_Znev3Pd"><s xml:id="_VSRHzvg">Among CVD risk factors, smoking increases atherosclerosis progression and the risk of atherosclerosis-related events by inducing oxidative stress, endothelial dysfunction, vascular inflammation, platelet aggregation and worsening of serum lipid profile <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s xml:id="_hHZpWn4">Smoking more strongly affects lower limb arteries and it is the most important cause of peripheral artery disease <ref type="bibr" target="#b2">[3]</ref>.</s><s xml:id="_PqrePEy">Smoking cessation slowly decreases the acquired risk for CVD but the risk does not decrease close to that of never-smokers until 10 years' cessation <ref type="bibr" target="#b3">[4]</ref>.</s></p><p xml:id="_2QmeQkY"><s xml:id="_PgmZesN">Alcoholic beverages consumption also influences cardiovascular health, but the mechanisms, magnitude and dose-dependency of the effects are still controversial <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s xml:id="_makhhPD">The Global Burden of Disease study concluded that the level of alcohol consumption that minimizes health impact is zero <ref type="bibr" target="#b6">[7]</ref>.</s><s xml:id="_CxcRKGK">However, the CALIBER (ClinicAl disease research using LInked Bespoke studies and Electronic health Records) study showed that moderate alcohol intake was associated with a lower incidence of cardiovascular events <ref type="bibr" target="#b7">[8]</ref> .</s><s xml:id="_xJZTC4W">A recent review published by Wood et al. <ref type="bibr" target="#b8">[9]</ref> concluded that the upper threshold of alcohol consumption for a lower risk of CVD, defined as an aggregate of myocardial infarction, other coronary heart disease and stroke, was 100 g/week.</s><s xml:id="_PeerX8a">This potential atherosclerosis protection from alcoholic beverages consumption is attributed to anti-oxidant effects which may be due, at least in part, to their actual alcohol content but also to non-alcoholic compounds, mainly polyphenols <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11]</ref>.</s><s xml:id="_GD6EzRU">Thus, the protective effect of alcoholic beverages, if present, would be greater in tobacco users, who suffer from increased oxidative stress.</s></p><p xml:id="_h7uctDs"><s xml:id="_JqKwq84">Subclinical atherosclerosis can be measured in several body locations, including carotid, femoral and coronary arteries.</s><s xml:id="_yAekgTc">This allows evidence of vascular disease to be found much earlier than when symptoms appear.</s><s xml:id="_Rez2mYv">Several studies have recently demonstrated that the presence of femoral plaques is a strong marker of coronary lesions <ref type="bibr" target="#b11">[12]</ref>.</s><s xml:id="_TuZxZg4">The Aragon Workers' Health Study (AWHS) <ref type="bibr" target="#b11">[12]</ref> and the Progression of Early Subclinical Atherosclerosis (PESA) <ref type="bibr" target="#b12">[13]</ref> study have shown that atherosclerotic femoral plaques are the most prevalent subclinical atherosclerotic alteration available non-invasively in the middle-aged population, and they are the atherosclerotic subclinical alteration with the strongest association with traditional CVD risk factors, especially with tobacco consumption <ref type="bibr" target="#b11">[12]</ref>, higher than carotid plaques.</s><s xml:id="_UYKZqnq">Alcohol consumption has been studied as a protective factor for subclinical atherosclerosis, mainly in cerebral and coronary territories <ref type="bibr" target="#b7">[8]</ref>, but it has not yet been studied in subclinical femoral atherosclerosis.</s><s xml:id="_3f8cTdJ">Thus, data about the effects of alcohol on early atherosclerosis are scarce.</s></p><p xml:id="_9JQ4EaZ"><s xml:id="_wsuQS3K">Given the controversial results that were previously published, we aim for two things: first, to address early associations, which can support the causal nature of the influence of the exposures; and second, to assess the possibility that alcohol partially counteracts strong pro-oxidant pro-atherosclerotic exposures such as tobacco.</s></p><p xml:id="_v3pwt2R"><s xml:id="_ab5rkUb">To that end we selected the femoral arteries as the territory most heavily affected by smoking.</s><s xml:id="_NmjP6JM">Thus, we aim to describe, for the first time to our knowledge, the possible influence of alcohol-and its dose-on subclinical atherosclerosis in femoral arteries among ever-smoking and never-smoking individuals.</s><s xml:id="_5hdFs5S">We studied this association on a sample of male workers from a factory in Spain.</s><s xml:id="_cqYB8nW">To broaden and contrast our results, we also analyzed these associations in carotid arteries.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jqhBDZx">METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Bppgutd">Participants</head><p xml:id="_8qM5a55"><s xml:id="_pqGPaR2">This cross-sectional study is based on AWHS, which is a prospective cohort, aimed to investigate the determinants of the development and progression of subclinical atherosclerosis.</s><s xml:id="_Rs2B6sj">Although the association of dietary factors, including alcohol, and smoking with atherosclerosis has been considered as an aim of AWHS in the protocol since the beginning, the details of the particular analysis presented in this report were not publicly pre-registered and consequently the results may be regarded as exploratory.</s><s xml:id="_ncuCtKB">Healthy middle-aged workers of the Opel Spain automobile assembly factory <ref type="bibr" target="#b13">[14]</ref>, attending their annual health examination between February 2009 and December 2012, were invited to participate in the study.</s><s xml:id="_cR2B473">From 2011 to 2014 participants aged between 39 and 59 years were additionally invited to undergo subclinical atherosclerosis measurements and to complete diet, behaviour and life-style questionnaires.</s><s xml:id="_b7hVpKh">Of the 2617 participants who attended these extended examinations, we excluded women due to the small number (n = 132) and those with missing data on subclinical atherosclerosis imaging examinations (n = 317), with missing data on CVD risk factors or relevant variables [body mass index (BMI), blood pressure] (n = 69).</s><s xml:id="_6PFKZJF">The final sample comprised 2099 men.</s><s xml:id="_kSFJaxp">All participants gave their written informed consent.</s><s xml:id="_6CVYx9V">The study was approved by the Clinical Research Ethics Committee of Aragon (CEICA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dgZguKB">Measurements</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_4efFXuN">Alcohol consumption</head><p xml:id="_Tdx4Dft"><s xml:id="_6XNvVJR">Usual diet over the preceding year was assessed using a 136-item semiquantitative food frequency questionnaire (FFQ).</s><s xml:id="_SFmQjc3">This was previously validated in Spain <ref type="bibr" target="#b14">[15]</ref>, and included a validated alcohol consumption assessment.</s><s xml:id="_KbyVUka">In this questionnaire, each participant provided information on the foods consumed during the year prior to the day of the interview.</s><s xml:id="_qchtcMp">The variable 'daily grams of alcohol' was calculated from the sum of the intake of red, rosé and white wine, beer and distillates.</s><s xml:id="_qkpjkPf">As this is an FFQ-derived variable, it is unevenly distributed.</s><s xml:id="_Z7jxcug">Also, the frequency of values 0 and 1 was high enough to compromise analysis of this variable as continuous.</s><s xml:id="_SpyzDtx">Thus, the sample was divided into four groups according to their consumption in: ≤ 1 (abstainers), ≥ 2 to &lt; 30, ≥ 30 to &lt; 60 and ≥ 60 g/day.</s><s xml:id="_GcEjKpz">In Spain, ≥ 30 g/day corresponds to three or more glasses of wine (100 ml), more than three beers (250 ml) or two spirit shots (50 ml) per day, and it was preferentially used here as a threshold versus 40 g/day [World Health Organization (WHO) risk of acute drinking problems classification] <ref type="bibr" target="#b15">[16]</ref> because the number of participants above 40 g/day was scarce in our sample.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_r4MCjWc">Atherosclerosis imaging</head><p xml:id="_qUbNgbY"><s xml:id="_bK54F9w">The presence of plaques in two vascular territories (carotid and femoral arteries) was assessed with a Philips IU22 ultrasound system (Philips Healthcare, Bothell, WA, USA).</s><s xml:id="_NPFjZMj">Ultrasound images were acquired with linear high-frequency two-dimensional probes (Philips Transducer L9-3; Philips Healthcare) using the Bioimage Study protocol for the carotid arteries <ref type="bibr" target="#b16">[17]</ref> and a specifically designed protocol for the femoral arteries <ref type="bibr" target="#b17">[18]</ref>.</s><s xml:id="_jDwZGph">Inspection sweeps were obtained at right and left sides for the carotid (common, internal and bulb) and femoral territories.</s><s xml:id="_YzUgvKp">We recorded plaque presence, number and thickness.</s><s xml:id="_NEAgjP6">Plaque was defined as a focal structure protruding ≥ 0.5 mm into the lumen or reaching a thickness ≥ 50% of the surrounding intima.</s><s xml:id="_fPCwu5j">All measurements were analyzed using electrocardiogram gated frames corresponding to end-diastole (R-wave) <ref type="bibr" target="#b18">[19]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_BFbP9sQ">Demographic, clinical and laboratory variables</head><p xml:id="_sz876fe"><s xml:id="_nnTX36D">Age, sex, clinical and laboratory data were obtained during the annual medical examination using standardized procedures, certified with ISO 9001-2008.</s><s xml:id="_kN4Xxju">The physical examination included height, weight and waist circumference and blood pressure.</s><s xml:id="_tmVEvRM">Total cholesterol, high-density lipoprotein cholesterol (HDL-c), triglycerides and fasting serum glucose concentrations were determined by enzyme analysis using the ILAB 650 analyzer from Instrumentation Laboratory (Bedford, MA, USA).</s><s xml:id="_crM47y5">Low-density lipoprotein cholesterol (LDL-c) was calculated using the Friedewald formula <ref type="bibr" target="#b19">[20]</ref> when the triglyceride levels were &lt; 400 mg/dl.</s><s xml:id="_bzZtJKw">In all participants, non-HDL-c was calculated by subtracting the HDL-c value from total cholesterol.</s><s xml:id="_s9xav9r">We defined arterial hypertension as having systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg or self-reported use of anti-hypertensive medication <ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_ccKWq35">Dyslipidaemia was defined as having total cholesterol ≥ 240 mg/dl, LDL-c ≥ 160 mg/dl, HDLc &lt; 40 mg/dl or self-reported use of lipid-lowering drugs <ref type="bibr" target="#b21">[22]</ref>.</s><s xml:id="_ftX8fKy">Diabetes was defined as fasting plasma ≥ 126 mg/dl or self-reported treatment with hypoglycaemic medication <ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_YsYJ9Fm">Smoking habits were categorized as current smoking if the participant reported having smoked in the last year, former smoking if the participant had smoked at least 50 cigarettes in his life-time, but not in the last year, and never smoking.</s><s xml:id="_U35xPYj">Ever smoking (current and former) versus never smoking was studied in the main analysis.</s><s xml:id="_kT5x2sS">Smoking was quantified with self-reported number of cigarettes per day.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_73f89Tg">Analysis</head><p xml:id="_TaGT8H7"><s xml:id="_QbESzJw">Descriptive statistics were reported as mean, standard deviation (SD) and percentage.</s><s xml:id="_Hr8td6s">Presence of atherosclerotic plaques in femoral and carotid arteries was fitted separately with logistic regression models, which included all groups of variables combining alcohol and smoking exposures (created through terms for category interactions between both variables) and adjusted for age, hypertension, dyslipidaemia and diabetes.</s><s xml:id="_MthJkmD">Linear combinations of coefficients were used to calculate odds ratios (OR) for plaque presence of each exposure with respect to the neversmoker/alcohol abstainer group and to test for relevant differences.</s><s xml:id="_4N6RvFB">In particular, ORs for the presence of plaque for each group of alcohol consumption with respect to the abstainers group were tested within each smoking stratum, and ORs for the presence of plaque for being ever-smoker with respect to never-smokers were tested within each alcohol consumption stratum.</s><s xml:id="_DwbQjwT">An overall interaction between both variables was also tested with the linear combination of all interaction terms in the regression.</s><s xml:id="_5karhfA">P-values below 0.05 were considered statistically significant.</s><s xml:id="_dez7GAc">To provide a detailed description of the influence of both variables on subclinical atherosclerosis, an analysis with smoking dose categories was performed.</s><s xml:id="_uCKCjVa">R statistical software (version 3.4.4)</s><s xml:id="_GauzeYE">was used for the analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_umnunRh">RESULTS</head><p xml:id="_7v9eQcj"><s xml:id="_9zRSwTr">The sample included 2099 men with a mean age of 50.9 (SD = 3.9) years.</s><s xml:id="_FwdRFzA">The number of participants reporting alcohol intake ≤ 1 (abstainers), ≥ 2 to &lt; 30, ≥ 30 to &lt; 60 and ≥ 60 g/day were 246 (11.7%), 1239 (59.0%), 501 (23.9%) and 113 (5.4%), respectively.</s><s xml:id="_x7YDZf8">Higher alcohol consumers were older.</s><s xml:id="_u366wtU">Systolic and diastolic blood pressure, total cholesterol, non-HDL-c, triglycerides and HDL-c rose with higher alcohol consumption.</s><s xml:id="_u83TzrM">Also, higher alcohol consumption was associated with belonging to the ever-smoking category (see Table <ref type="table" target="#tab_0">1</ref>), with unadjusted OR for each increasing category 1.38 (95% CI = 1.19, 1.60; P for trend &lt; 0.001).</s></p><p xml:id="_JUTqQww"><s xml:id="_QExXSZy">At least one femoral plaque was present in 166 of the 474 never-smokers (35.0%) and in 1024 of the 1625 ever-smokers (63.0%) (fully adjusted OR = 3.00; 95% CI = 2.40, 3.74; P &lt; 0.001).</s><s xml:id="_xe6M63w">We found no association between different levels of alcohol intake and the likelihood of developing subclinical atherosclerosis in femoral arteries in never-smoking participants (see Table <ref type="table" target="#tab_1">2</ref> and Fig. <ref type="figure">1</ref>).</s><s xml:id="_zYFydPM">The odds for having a femoral plaque was 3.70 (95% CI = 2.00, 6.98) times higher among the ever-smoker/alcohol abstainer group than among the never-smoker/alcohol abstainer group.</s><s xml:id="_rgwQxnw">The OR was 2.59 (95% CI = 1.49, 4.48) in those ever-smokers who consumed 2 g of alcohol/day or more but fewer than 30 g/day compared to the never-smoker/alcohol abstainer group.</s><s xml:id="_fjsUU92">Testing the difference between these ever-smokers groups, the group of eversmokers who consumed 2 g/day or more but fewer than 30 g/day presented a significantly lower atherosclerosis prevalence (fully adjusted OR = 0.70; 95% CI = 0.49, 0.99; P = 0.044) than the ever-smoker/alcohol abstainer group, although still higher than never-smokers who consumed alcohol in the same amount (fully adjusted OR = 2.73; 95% CI = 2.07, 3.61; P &lt; 0.001).</s><s xml:id="_XNdeUHU">At any alcohol consumption level, odds for femoral plaques were always higher among ever-smokers than among never-smokers (fully adjusted ORs ranging between 2.73 and 6.32; P ≤ 0.001) (see Table <ref type="table" target="#tab_1">2</ref> and Fig. <ref type="figure">1</ref>).</s><s xml:id="_kcSaevY">Although this study was not sized to provide adequate statistical power for it, a test for an overall interaction term between all drinking and smoking categories was performed and significance was not reached (P = 0.165).</s></p><p xml:id="_yvDsvuG"><s xml:id="_zahfrgp">A detailed observation of the combined influence of alcohol and tobacco on femoral atherosclerosis considering smoking dose suggests that the U-shaped association tends to appear at higher smoking consumption levels (see Fig. <ref type="figure">2</ref> and Supporting information, Table <ref type="table" target="#tab_0">S1</ref>).</s></p><p xml:id="_HU5MgAm"><s xml:id="_t53ugjY">At least one carotid plaque was present in 123 of the 474 never-smokers (25.9%) and in 647 of the 1625 ever-smokers (39.8%) (OR = 1.89).</s><s xml:id="_kKMuMEa">We found no association between different levels of alcohol intake and the likelihood of developing subclinical atherosclerosis in carotid arteries in any of the two groups (see Supporting information, Table <ref type="table" target="#tab_1">S2</ref>).</s><s xml:id="_gyCG6f4">We did not seek a detailed smoking dose analysis, given the weaker association of carotid  atherosclerosis with smoking and the absence of association with alcohol.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pcEKGbm">DISCUSSION</head><p xml:id="_pkgZHkt"><s xml:id="_NPhpaNR">In this study we could not demonstrate a protective influence of alcohol on femoral subclinical atherosclerosis among never-smokers.</s><s xml:id="_2PYHcZe">However, among ever-smokers, who are participants with an increased prevalence of femoral subclinical atherosclerosis, it appears that a pattern of moderate alcohol consumption of between 2 and 30 g/day is associated with a lower prevalence of subclinical atherosclerosis in femoral arteries, independently of other risk factors.</s><s xml:id="_2BJUfJH">The prevalence was still greater than that of never-smokers with the same level of alcohol consumption.</s></p><p xml:id="_GG9sX6q"><s xml:id="_XFVabnS">No previous studies have analyzed this association on early atherosclerosis that can explain, at least in part, the overall beneficial effect on latter CVD observed in some observational studies.</s></p><p xml:id="_NPVXN9f"><s xml:id="_7ssksZT">Information on the association of alcohol consumption and femoral atherosclerosis is scarce.</s><s xml:id="_S9Av7Yg">Most studies analyzing the role of alcohol consumption have mainly focused on the presence of atherosclerosis in coronary and cerebral territories or on coronary and cerebrovascular clinical outcomes, and very few have focused on carotid territory <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b23">24]</ref>.</s><s xml:id="_wq798a8">However, in the CALIBER study <ref type="bibr" target="#b7">[8]</ref>, among 1.93 million adults, alcohol consumption of 140 g/week was associated with a lower risk of myocardial infarction, Figure <ref type="figure">2</ref> Odds ratio for the presence of femoral plaque according to levels of alcohol intake and smoking exposures Figure <ref type="figure">1</ref> Odds ratio (95% confidence interval) for the presence of femoral plaque according to levels of alcohol intake and smoking habit ischaemic stroke and peripheral arterial disease.</s><s xml:id="_G6PCsSG">The ARIC study found a protective effect of alcohol on incident peripheral arterial and coronary heart disease <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b25">26]</ref>, but none on brain disease <ref type="bibr" target="#b26">[27]</ref>.</s><s xml:id="_cF2bSB2">Research of an alcohol effect on subclinical femoral atherosclerosis was lacking.</s><s xml:id="_YKNVvFW">With respect to dose-effects, a recent analysis <ref type="bibr" target="#b8">[9]</ref> of 599 912 current drinkers with an average age of 57 years belonging to 83 prospective studies determined a positive and progressively increasing association with alcohol consumption for all-cause mortality, with the lowest risk for those consuming below 100 g/week.</s><s xml:id="_HpHx6Cn">However, for the aggregate of CVD outcomes (myocardial infarction, other coronary heart disease and stroke) there was a J-shaped association.</s><s xml:id="_2bhs8Dp">In another systematic review and meta-analysis of longitudinal cohort studies, comparing non-drinkers with alcohol drinkers, light to moderate alcohol consumption was associated with a reduced risk of coronary heart disease <ref type="bibr" target="#b27">[28]</ref>.</s><s xml:id="_JysuZfD">These studies paid very limited attention to exposure to smoking (CALIBER analyses were simply adjusted for smoking), and none considered the proportion of exposure to it nor to the possibility of an effect restricted to smokers.</s><s xml:id="_YfhmB8T">This is especially important because alcohol consumption is frequently coincident with the use of tobacco <ref type="bibr" target="#b28">[29,</ref><ref type="bibr" target="#b29">30]</ref>, and if the effect occurs only among smokers, observing the overall effect could depend on tobacco being consumed by a large proportion of the studied population.</s></p><p xml:id="_aB2yWZS"><s xml:id="_tzzbDKT">Current smoking and cumulative exposure are significant risk factors for CVD <ref type="bibr" target="#b1">[2]</ref> and, in particular, very strong factors for peripheral arterial disease <ref type="bibr" target="#b30">[31]</ref>.</s><s xml:id="_2WACYMz">We have found a protective role of moderate alcohol intake in the femoral territory, which is the one most affected by smoking, and interestingly, it was only observable in current or former smokers.</s><s xml:id="_eP8M3ZC">Smoking is an important modifiable risk factor, and it is addressed as a primary intervention aim in most guides <ref type="bibr" target="#b31">[32,</ref><ref type="bibr" target="#b32">33]</ref>.</s><s xml:id="_c9KAgTf">Probably, the potential benefits of moderate alcohol consumption may only be apparent among groups with a substantial smoking exposure.</s><s xml:id="_KDzJMs9">Eradicating tobacco use is a long-term goal of public health strategies.</s><s xml:id="_Sp9PpSs">Thus, in future societies in which this achievement has been attained, the benefits of moderate drinking may fade off as the population becomes mainly non-smoker.</s></p><p xml:id="_nqN7byF"><s xml:id="_2p7KMNF">There are several possible explanations for our findings.</s><s xml:id="_hNs48rq">It is possible that moderate alcohol consumption specifically counteracts the harmful effects of tobacco.</s><s xml:id="_rXvH3d2">Tobacco contains many oxidative substances <ref type="bibr" target="#b33">[34]</ref> and there are many basic science studies that support the anti-oxidant properties of alcoholic beverages <ref type="bibr" target="#b34">[35]</ref>.</s><s xml:id="_Thr6fJT">There has been limited success in isolating a single anti-oxidant component <ref type="bibr" target="#b35">[36,</ref><ref type="bibr" target="#b36">37]</ref>, as both alcohol <ref type="bibr" target="#b37">[38]</ref> and other compounds <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11]</ref> seem to be responsible for those properties.</s><s xml:id="_yx23MwR">That the association is observed only in smokers and only in femoral arteries, which are affected much more than carotid ones by tobacco, suggests that this could be one of the main mechanisms that explain our results.</s><s xml:id="_y28DNKj">Furthermore, moderate alcohol consumption was associated with a lower risk of incident peripheral arterial disease in the CALIBER <ref type="bibr" target="#b7">[8]</ref> and the Atherosclerosis Risk in Communities (ARIC) studies <ref type="bibr" target="#b24">[25]</ref>, in contrast with a null effect in cerebral vascular disease in the latter <ref type="bibr" target="#b26">[27]</ref>.</s><s xml:id="_sa4hGkA">Similar results have been replicated in other populations <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b39">40]</ref>, demonstrating protective effects in peripheral territories.</s><s xml:id="_DzThfXh">It is also possible that moderate alcohol consumption reflects a healthier life-style, such as a Mediterranean diet, even in the presence of smoking, and that it is an epiphenomenon without causal relationship with atherosclerosis.</s><s xml:id="_JbZzpvF">This seems unlikely, because the beneficial influence of moderate alcohol consumption does not appear in neversmokers, and appears not only in moderate smokers but also in heavy smokers.</s><s xml:id="_cJQ6Egp">It is also possible that moderate alcohol consumption acts in the prevention of all types of atherosclerosis if there is considerable risk, regardless of the causal risk factors.</s><s xml:id="_bChPZrK">It is well known that alcohol consumption is associated with an increase in HDL-c which, in turn, is a protective factor for CVD.</s><s xml:id="_qszAEbY">However, in our study the observed benefit is independent of the presence of dyslipidaemia, and it is not observed in carotid territory, which does not support a general anti-atherosclerotic influence.</s></p><p xml:id="_Jd3CsZ8"><s xml:id="_qhn46ya">To the best of our knowledge, this is the first study to evaluate the impact of moderate alcohol consumption on subclinical femoral atherosclerosis, and to take smoking influence into consideration.</s><s xml:id="_8B7y2BD">Furthermore, it has the strength of having been carried out with standardized protocols and using high-quality data collection methods to obtain information on subclinical atherosclerosis in both carotid and femoral territories.</s><s xml:id="_96MmQ5z">However, it has also several limitations.</s><s xml:id="_2GBag3P">First, the cross-sectional design does not allow us to assume causality and temporality of the associations found.</s><s xml:id="_4VhsAWB">Second, we only included men, so our result cannot be translated to women.</s><s xml:id="_dqNvuqg">Third, although alcohol intake assessment includes personal interviews by trained interviewers, we have to assume that the use of FFQ can lead to some misclassification <ref type="bibr" target="#b40">[41]</ref> and is less precise than other tools, even though scientific literature supports that this questionnaire classifies usual intakes correctly.</s><s xml:id="_Yqa3vHb">Unfortunately, we have not been able to break down the current group of abstainers into life-long non-drinkers and exdrinkers, so the combination of these groups can lead to an overestimation of the protective influence of moderate alcohol consumption.</s><s xml:id="_5jNHYdd">Also, the never-smokers group size was smaller than the ever-smokers group size, which means that finding associations among those participants suffers from smaller statistical power.</s><s xml:id="_5v8FRC2">Nonetheless, the dose-response for alcohol association with atherosclerosis was nearly flat, and there were no visible trends where non-significance could be attributed to lack of power.</s><s xml:id="_hcjgrva">As an example, assuming that in the never-smoker stratum 'abstainers' and '≥ 2 to &lt; 30 g/day' categories are of the same size as we have (63 and 316, respectively), and that the prevalence of femoral plaque among 'abstainers' is 0.35, this sample would have 80% power to detect a difference in plaque prevalence of approximately 0.15 less among the '≥ 2 to &lt; 30 g/day' category.</s><s xml:id="_qaWkyk5">Only a 0.03 difference was observed between these groups.</s></p><p xml:id="_fhrnCxd"><s xml:id="_qxVRXPQ">Alcohol use has been ranked as the seventh leading risk factor for premature death and disability <ref type="bibr" target="#b6">[7]</ref>.</s><s xml:id="_fhTMHvf">The recommendation on alcohol consumption varies, and it is subject to continuous review.</s><s xml:id="_cPWvjx7">From the point of view of public health, the prevention of alcohol related problems, derived fundamentally from certain behaviours such as compulsive alcohol consumption, is a social policy issue, especially in teenagers and young adults.</s><s xml:id="_HMMVJ4C">Our study suggests that it may have a neutral effect on atherosclerosis in future tobacco-free societies, making it easier to supply more straightforward recommendations for alcohol.</s></p><p xml:id="_ezVYHE4"><s xml:id="_b84N5ZT">Future studies of alcohol potential protective effect should address its potential interaction with other risk factors in samples at high risk for atherosclerosis in which expected progression could be slowed down in any territory.</s><s xml:id="_shSzQ8k">Also, particular attention devoted to interaction with factors that impact oxidative stress will clarify whether or not the nature of the risk factor is relevant.</s><s xml:id="_t4BMzvp">In any case, public health implications that we have outlined above (potential protection fades away in tobacco-free societies) remain relevant, no matter the mechanistic explanation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_trQAXEp">CONCLUSIONS</head><p xml:id="_YDJRNZX"><s xml:id="_nwPJau9">In conclusion, we have observed that moderate alcohol consumption has no association with subclinical femoral or carotid atherosclerosis among never-smokers, but a protective influence on femoral atherosclerosis among smokers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_RBjPH2z">Declaration of interests</head><p xml:id="_XZmTKMv"><s xml:id="_SfNynZV">None.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p xml:id="_Mf99kb8"><s xml:id="_eGCDSEG">Baseline characteristics of study participants according to levels of alcohol intake.</s></p></div></figDesc><table><row><cell></cell><cell>Overall</cell><cell>Abstainers</cell><cell>≥ 2 to &lt; 30</cell><cell>≥ 30 to &lt; 60</cell><cell>≥ 60</cell><cell>P-value</cell></row><row><cell>n</cell><cell>2099</cell><cell>246</cell><cell>1239</cell><cell>501</cell><cell>113</cell><cell></cell></row><row><cell>Age, years</cell><cell>50.9 (3.9)</cell><cell>50.7 (4.1)</cell><cell>50.6 (4.0)</cell><cell>51.5 (3.6)</cell><cell>51.8 (3.1)</cell><cell>&lt; 0.001</cell></row><row><cell>BMI, kg/m 2</cell><cell>27.6 (3.3)</cell><cell>27.4 (3.5)</cell><cell>27.6 (3.2)</cell><cell>27.7 (3.3)</cell><cell>28.1 (3.6)</cell><cell>0.341</cell></row><row><cell>Waist circumference, cm</cell><cell>97.3 (8.8)</cell><cell>96.6 (9.0)</cell><cell>97.3 (8.8)</cell><cell>97.1 (8.8)</cell><cell>98.6 (9.1)</cell><cell>0.254</cell></row><row><cell>Systolic blood pressure, mm Hg</cell><cell>125.3 (13.9)</cell><cell>124.3 (13.3)</cell><cell>124.8 (13.6)</cell><cell>126.4 (15.1)</cell><cell>129.2 (12.7)</cell><cell>0.002</cell></row><row><cell>Diastolic blood pressure, mm Hg</cell><cell>82.4 (9.4)</cell><cell>80.9 (8.9)</cell><cell>82.1 (9.4)</cell><cell>83.1 (9.8)</cell><cell>85.0 (8.7)</cell><cell>&lt; 0.001</cell></row><row><cell>Total cholesterol, mg/dl</cell><cell>220.0 (36.4)</cell><cell>212.1 (39.1)</cell><cell>218.9 (35.8)</cell><cell>224.9 (35.7)</cell><cell>227.7 (35.4)</cell><cell>&lt; 0.001</cell></row><row><cell>HDL-c, mg/dl</cell><cell>53.1 (11.4)</cell><cell>49.1 (10.8)</cell><cell>53.0 (10.9)</cell><cell>54.5 (12.1)</cell><cell>56.2 (11.4)</cell><cell>&lt; 0.001</cell></row><row><cell>Non-HDL-c, mg/dl</cell><cell>167.0 (35.2)</cell><cell>162.9 (37.3)</cell><cell>166.0 (34.9)</cell><cell>170.4 (34.9)</cell><cell>171.5 (34.4)</cell><cell>0.013</cell></row><row><cell>LDL-c, mg/dl</cell><cell>137.8 (31.4)</cell><cell>135.1 (33.3)</cell><cell>137.8 (31.2)</cell><cell>139.0 (31.1)</cell><cell>138.6 (31.3)</cell><cell>0.445</cell></row><row><cell>Triglycerides, mg/dl</cell><cell>150.0 (96.9)</cell><cell>147.9 (126.2)</cell><cell>143.1 (85.3)</cell><cell>161.8 (103.0)</cell><cell>176.9 (107.1)</cell><cell>&lt; 0.001</cell></row><row><cell>Fasting glucose, mg/dl</cell><cell>97.7 (17.5)</cell><cell>96.6 (19.3)</cell><cell>97.4 (17.2)</cell><cell>98.5 (18.2)</cell><cell>99.7 (13.5)</cell><cell>0.297</cell></row><row><cell>Ever-smokers, %</cell><cell>77.4 (1625)</cell><cell>74.4 (183)</cell><cell>74.5 (923)</cell><cell>84.6 (424)</cell><cell>84.1 (95)</cell><cell>&lt; 0.001</cell></row><row><cell>Hypertension, %</cell><cell>37.4 (784)</cell><cell>34.1 (84)</cell><cell>34.9 (433)</cell><cell>40.3 (202)</cell><cell>57.5 (65)</cell><cell>&lt; 0.001</cell></row><row><cell>Dyslipidaemia, %</cell><cell>49.2 (1032)</cell><cell>52.0 (128)</cell><cell>47.2 (585)</cell><cell>52.5 (263)</cell><cell>49.6 (56)</cell><cell>0.177</cell></row><row><cell>Diabetes, %</cell><cell>5.7 (120)</cell><cell>8.1 (20)</cell><cell>4.8 (59)</cell><cell>7.2 (36)</cell><cell>4.4 (5)</cell><cell>0.078</cell></row></table><note xml:id="_QtEbBKJ"><p><s xml:id="_VDfb46G">BMI = body mass index; HDL-c = high-density lipoprotein cholesterol; LDL-c = low-density lipoprotein cholesterol.</s><s xml:id="_xpcSMjB">Values are mean (standard deviation) or % (number).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p xml:id="_rCgT4HJ"><s xml:id="_rG9Crx4">Odds ratio [95% confidence interval (CI)] for the presence of femoral plaque according to levels of alcohol intake and smoking habit.</s></p></div></figDesc><table><row><cell></cell><cell>Never-smokers</cell><cell></cell><cell></cell><cell>Ever-smokers</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>n/N</cell><cell>OR (95% CI)</cell><cell>P*1</cell><cell>n/N</cell><cell>OR (95% CI)</cell><cell>P * 1</cell><cell>P * 2</cell></row><row><cell>Abstainers</cell><cell>23/63</cell><cell>1.00 (ref)</cell><cell>ref</cell><cell>124/183</cell><cell>3.70 (2.00, 6.98)</cell><cell>Ref.</cell><cell>&lt; 0.001</cell></row><row><cell>≥2 &lt; 30 g/day</cell><cell>104/316</cell><cell>0.95 (0.53, 1.72)</cell><cell>0.854</cell><cell>550/923</cell><cell>2.59 (1.49, 4.48)</cell><cell>0.044</cell><cell>&lt; 0.001</cell></row><row><cell>≥30 &lt; 60 g/day</cell><cell>33/77</cell><cell>1.14 (0.56, 2.32)</cell><cell>0.718</cell><cell>280/424</cell><cell>3.17 (1.79, 5.61)</cell><cell>0.426</cell><cell>&lt; 0.001</cell></row><row><cell>≥60 g/day</cell><cell>6/18</cell><cell>0.69 (0.21, 2.13)</cell><cell>0.533</cell><cell>70/95</cell><cell>4.39 (2.16, 8.93)</cell><cell>0.556</cell><cell>0.001</cell></row></table><note xml:id="_Y9jtpdX"><p><s xml:id="_tHSSkrb">Adjusted odds ratios were calculated with logistic regression models adjusted for age, hypertension, dyslipidaemia and diabetes.</s><s xml:id="_qQpdWhP">ORs in the table used as reference the never-smoker/alcohol abstainer group.</s><s xml:id="_gwZvhxV">P-values shown are not for testing these ORs, but for specific intra-strata comparisons.</s><s xml:id="_ttqQrED">P-values below 0.05 appear highlighted in bold type.</s><s xml:id="_SGtnCDM">N: number of participants in the smoking and alcohol consumption group; n: number of participants with at least one plaque; P*1: Level of significance of the OR for the presence of plaque for each group of alcohol consumption with respect to the abstainers group, within each smoking stratum; P*2: Level of significance of the OR for the presence of plaque for being ever-smoker with respect to never-smokers, within each alcohol consumption stratum.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_HmkJxwX"><s xml:id="_5Ua7t3v">© 2020 Society for the Study of Addiction Addiction, 115, 1754-1761 13600443, 2020, 9, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/add.15012</s><s xml:id="_C7DzjmW">by University Of Iowa Libraries -Serials Acquisitions, Wiley Online Library on [04/08/2025].</s><s xml:id="_gSxTUJk">See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions)</s><s xml:id="_WKGzvtw">on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_junTZzN">Acknowledgements</head><p xml:id="_eeWm3bq"><s xml:id="_34RM3mR">This study was supported in part by <rs type="funder">CIBERCV</rs> and grants <rs type="grantNumber">PI17/10704</rs>, <rs type="grantNumber">PI18/01929</rs>, from the <rs type="funder">Instituto de Salud Carlos III</rs> (co-supported by the <rs type="funder">European Regional Development Fund</rs> '<rs type="programName">Investing in your future</rs>').</s><s xml:id="_RPRQzD7">M.L.'s research activity is funded by <rs type="funder">Agencia Aragonesa para la Investigación y el Desarrollo (ARAID)</rs>.</s><s xml:id="_PMutk4F">The authors thank the study participants, doctors and health-care professionals at the Opel factory.</s><s xml:id="_uCtHfvR">The authors also thank the <rs type="institution">AWHS</rs> technical staff.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_EvDQmme">
					<idno type="grant-number">PI17/10704</idno>
				</org>
				<org type="funding" xml:id="_Wc6yAJ8">
					<idno type="grant-number">PI18/01929</idno>
				</org>
				<org type="funding" xml:id="_dgdfEKu">
					<orgName type="program" subtype="full">Investing in your future</orgName>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PNFyRPX">Supporting Information</head><p xml:id="_Hry2s2W"><s xml:id="_Vgf3dd7">Additional supporting information may be found online in the Supporting Information section at the end of the article.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ES43qhZ">Table S1</head><p xml:id="_qsfjkDx"><s xml:id="_nSEkUG3">Odds ratio (95%CI) for the presence of femoral plaque according to levels of alcohol intake and smokingexposures.</s><s xml:id="_pd24Ats">Table <ref type="table">S2</ref> Odds ratio (95%CI) for the presence of carotid plaque according to levels of alcohol intake and smoking.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_tGGfk3S">Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches</title>
		<author>
			<persName><forename type="first">G</forename><surname>Siasos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Tsigkou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kokkou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Oikonomou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vavuranakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vlachopoulos</surname></persName>
		</author>
		<idno type="DOI">10.2174/092986732134141015161539</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NGDZgQ7">Curr Med Chem</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="3936" to="3948" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Siasos G., Tsigkou V., Kokkou E., Oikonomou E., Vavuranakis M., Vlachopoulos C. et al. Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches. Curr Med Chem 2014; 21: 3936-48.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_Yz8hfvP">Cigarette smoking and cardiovascular events: role of inflammation and subclinical atherosclerosis from the MultiEthnic study of atherosclerosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Mcevoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Blaha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Defilippis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Lima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Bluemke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Hundley</surname></persName>
		</author>
		<idno type="DOI">10.1161/atvbaha.114.304562</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xp9nRn8">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="700" to="709" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McEvoy J. W., Blaha M. J., DeFilippis A. P., Lima J. A., Bluemke D. A., Hundley W. G. et al. Cigarette smoking and cardiovascular events: role of inflammation and subclinical atherosclerosis from the MultiEthnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2015; 35: 700-9.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_5HewZEa">Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rudan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J I</forename><surname>Fowkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rahimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G R</forename><surname>Fowkes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_35Nd6zD">Lancet Glob Health</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1020" to="e1030" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Song P., Rudan D., Zhu Y., Fowkes F. J. I., Rahimi K., Fowkes F. G. R. et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 2019; 7: e1020-e1030.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_2z6FrNw">Association of Smoking Cessation with subsequent risk of cardiovascular disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Duncan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Freiberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Greevy</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kundu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Vasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Tindle</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2019.10298</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fX76Gg8">JAMA</title>
		<imprint>
			<biblScope unit="volume">322</biblScope>
			<biblScope unit="page" from="642" to="650" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Duncan M. S., Freiberg M. S., Greevy R. A. Jr., Kundu S., Vasan R. S., Tindle H. A. Association of Smoking Cessation with subsequent risk of cardiovascular disease. JAMA 2019; 322: 642-50.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_wD4A2r9">Cardiovascular risks and benefits of moderate and heavy alcohol consumption</title>
		<author>
			<persName><forename type="first">J</forename><surname>Fernandez-Sola</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrcardio.2015.91</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tfT3jgF">Nat Rev Cardiol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="576" to="587" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fernandez-Sola J. Cardiovascular risks and benefits of moder- ate and heavy alcohol consumption. Nat Rev Cardiol 2015; 12: 576-87.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_gf8Nc7G">The risks and benefits of moderate alcohol consumption: there remains much to learn</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Leifer</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jchf.2017.09.005</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SjHxMjG">JACC Heart Fail</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="845" to="847" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Leifer E. S. The risks and benefits of moderate alcohol consumption: there remains much to learn. JACC Heart Fail 2017; 5: 845-7.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_mmahCMR">Global Burden of Disease Alcohol Collaborators Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the global burden of disease study 2016</title>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yEgAnBV">Lancet</title>
		<imprint>
			<biblScope unit="volume">392</biblScope>
			<biblScope unit="page" from="1015" to="1035" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Global Burden of Disease Alcohol Collaborators Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet 2018; 392: 1015-35.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_N8YF8xu">Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Daskalopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rapsomaniki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Britton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bobak</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.j909</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_F7knWPV">BMJ</title>
		<imprint>
			<biblScope unit="volume">356</biblScope>
			<biblScope unit="page">909</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bell S., Daskalopoulou M., Rapsomaniki E., George J., Britton A., Bobak M. et al. Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records. BMJ 2017; 356: j909.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_CyQ4ZAu">Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kaptoge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Butterworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Willeit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Warnakula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bolton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sV8t8Pv">Lancet</title>
		<imprint>
			<biblScope unit="volume">391</biblScope>
			<biblScope unit="page" from="1513" to="1523" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wood A. M., Kaptoge S., Butterworth A. S., Willeit P., Warnakula S., Bolton T. et al. Risk thresholds for alcohol con- sumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 2018; 391: 1513-23.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_q3ZSaCH">Effects of moderate beer consumption on health and disease: a consensus document</title>
		<author>
			<persName><forename type="first">G</forename><surname>De Gaetano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Costanzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Castelnuovo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Badimon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bejko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Alkerwi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_a3NFSe4">Nutr Metab Cardiovasc Dis</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="443" to="467" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">de Gaetano G., Costanzo S., Di Castelnuovo A., Badimon L., Bejko D., Alkerwi A. et al. Effects of moderate beer consump- tion on health and disease: a consensus document. Nutr Metab Cardiovasc Dis 2016; 26: 443-67.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_mxPEsyK">The impact of moderate wine consumption on health</title>
		<author>
			<persName><forename type="first">A</forename><surname>Artero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Tarin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VJfFTvN">Maturitas</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="3" to="13" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Artero A., Tarin J. J., Cano A. The impact of moderate wine consumption on health. Maturitas 2015; 80: 3-13.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_pdX7zEq">Femoral and carotid subclinical atherosclerosis association with risk factors and coronary calcium: the AWHS study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Laclaustra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Casasnovas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fernandez-Ortiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fuster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leon-Latre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Jimenez-Borreguero</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2015.12.056</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yeyXvUN">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="1263" to="1274" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Laclaustra M., Casasnovas J. A., Fernandez-Ortiz A., Fuster V., Leon-Latre M., Jimenez-Borreguero L. J. et al. Femoral and carotid subclinical atherosclerosis association with risk factors and coronary calcium: the AWHS study. J Am Coll Cardiol 2016; 67: 1263-74.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_fqMuNMA">Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (progression of early subclinical atherosclerosis) study</title>
		<author>
			<persName><forename type="first">L</forename><surname>Fernandez-Friera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Penalvo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fernandez-Ortiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ibanez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lopez-Melgar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laclaustra</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.114.014310</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RQS3XrW">Circulation</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="2104" to="2113" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fernandez-Friera L., Penalvo J. L., Fernandez-Ortiz A., Ibanez B., Lopez-Melgar B., Laclaustra M. et al. Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (progres- sion of early subclinical atherosclerosis) study. Circulation 2015; 131: 2104-13.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_atqZFZa">Aragon workers&apos; health studydesign and cohort description</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Casasnovas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Alcaide</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Civeira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Guallar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ibanez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Borreguero</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2261-12-45</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5ERnwTP">BMC Cardiovasc Disord</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">45</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Casasnovas J. A., Alcaide V., Civeira F., Guallar E., Ibanez B., Borreguero J. J. et al. Aragon workers&apos; health study- design and cohort description. BMC Cardiovasc Disord 2012; 12: 45.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_JWxZKUE">Development and validation of a food frequency questionnaire in Spain</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Martin-Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Boyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gorgojo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Maisonneuve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Fernandez-Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Salvini</surname></persName>
		</author>
		<idno type="DOI">10.1093/ije/22.3.512</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dMbxQ2J">Int J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="512" to="519" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Martin-Moreno J. M., Boyle P., Gorgojo L., Maisonneuve P., Fernandez-Rodriguez J. C., Salvini S. et al. Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 1993; 22: 512-9.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<idno type="DOI">10.26719/2015.21.6.379</idno>
		<title level="m" xml:id="_PkmSU2Y">World Health Organization International Guide for Monitoring Alcohol Consumption and Related Harm</title>
		<meeting><address><addrLine>Geneva; Switzerland</addrLine></address></meeting>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization International Guide for Monitoring Alcohol Consumption and Related Harm. World Health Organiza- tion. Geneva: Switzerland; 2000.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_CfpCRa3">The BioImage study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease -study design and objectives</title>
		<author>
			<persName><forename type="first">P</forename><surname>Muntendam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mccall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sanz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Falk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fuster</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ahj.2010.02.021</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rw9PJQw">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="49" to="57" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Muntendam P., McCall C., Sanz J., Falk E., Fuster V. The BioImage study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease -study design and objectives. Am Heart J 2010; 160: 49-57; e1.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_WWxYq3M">Femoral atherosclerosis in heterozygous familial hypercholesterolemia: influence of the genetic defect</title>
		<author>
			<persName><forename type="first">M</forename><surname>Junyent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gilabert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zambon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pocovi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mallen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cofan</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1567-5688(08)70122-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5ZmYzaU">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="580" to="586" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Junyent M., Gilabert R., Zambon D., Pocovi M., Mallen M., Cofan M. et al. Femoral atherosclerosis in heterozygous famil- ial hypercholesterolemia: influence of the genetic defect. Arterioscler Thromb Vasc Biol 2008; 28: 580-6.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_hS85gUd">Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Inaba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Bergmann</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.atherosclerosis.2011.06.044</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WbvdyWQ">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">220</biblScope>
			<biblScope unit="page" from="128" to="133" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Inaba Y., Chen J. A., Bergmann S. R. Carotid plaque, com- pared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis 2012; 220: 128-33.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_pe2T9JW">Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Friedewald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">I</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Fredrickson</surname></persName>
		</author>
		<idno type="DOI">10.1093/clinchem/18.6.499</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ffxfYKW">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="499" to="502" />
			<date type="published" when="1972">1972</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_WFaAXQs">American heart association guide for improving cardiovascular health at the community level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Pearson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Palaniappan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">T</forename><surname>Artinian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Carnethon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Criqui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Daniels</surname></persName>
		</author>
		<idno type="DOI">10.1161/cir.0b013e31828f8a94</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nQbPsFU">Circulation</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="1730" to="1753" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pearson T. A., Palaniappan L. P., Artinian N. T., Carnethon M. R., Criqui M. H., Daniels S. R. et al. American heart associa- tion guide for improving cardiovascular health at the community level, 2013 update: a scientific statement for pub- lic health practitioners, healthcare providers, and health policy makers. Circulation 2013; 127: 1730-53.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_dn5rVTV">National Cholesterol Education Program Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report</title>
		<idno type="DOI">10.1161/circ.106.25.3143</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RPSYWRV">Circulation</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="3143" to="3421" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">National Cholesterol Education Program Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood choles- terol in adults (adult treatment panel III) final report. Circulation 2002; 106: 3143-421.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_NYfXaZ8">Association between alcohol consumption and subclinical carotid atherosclerosis: the study of health in Pomerania</title>
		<author>
			<persName><forename type="first">U</forename><surname>Schminke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Luedemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Alte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mitusch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Wood</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.str.0000173159.65228.68</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9Ez9RgQ">Stroke</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1746" to="1752" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schminke U., Luedemann J., Berger K., Alte D., Mitusch R., Wood W. G. et al. Association between alcohol consumption and subclinical carotid atherosclerosis: the study of health in Pomerania. Stroke 2005; 36: 1746-52.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_tqcRDBd">Effects of moderate and high doses of alcohol on carotid atherogenesis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Bo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Marchioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bosone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Soragna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Albergati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Micieli</surname></persName>
		</author>
		<idno type="DOI">10.1159/000052102</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2kJPrep">Eur Neurol</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="97" to="103" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bo P., Marchioni E., Bosone D., Soragna D., Albergati A., Micieli G. et al. Effects of moderate and high doses of alcohol on carotid atherogenesis. Eur Neurol 2001; 45: 97-103.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_s5VGXvh">Dietary intake and peripheral arterial disease incidence in middle-aged adults: the atherosclerosis risk in communities (ARIC) study</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Ogilvie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Lutsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Heiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Folsom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Steffen</surname></persName>
		</author>
		<idno type="DOI">10.3945/ajcn.116.137497</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sjUu9Rz">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="651" to="659" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ogilvie R. P., Lutsey P. L., Heiss G., Folsom A. R., Steffen L. M. Dietary intake and peripheral arterial disease incidence in middle-aged adults: the atherosclerosis risk in communities (ARIC) study. Am J Clin Nutr 2017; 105: 651-9.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_dusdT7N">Association between alcoholic beverage consumption and incidence of coronary heart disease in whites and blacks: the atherosclerosis risk in communities study</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Fuchs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Chambless</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Folsom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Eigenbrodt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Duncan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gilbert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MH4VnmQ">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="466" to="474" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fuchs F. D., Chambless L. E., Folsom A. R., Eigenbrodt M. L., Duncan B. B., Gilbert A. et al. Association between alcoholic beverage consumption and incidence of coronary heart dis- ease in whites and blacks: the atherosclerosis risk in communities study. Am J Epidemiol 2004; 160: 466-74.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_Rpucycj">Alcohol intake and cerebral abnormalities on magnetic resonance imaging in a community-based population of middle-aged adults: the atherosclerosis risk in communities (ARIC) study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Eigenbrodt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Mosley</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Hutchinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Folsom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Harris</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.str.0000105929.88691.8e</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NAdsE8J">Stroke</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="16" to="21" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ding J., Eigenbrodt M. L., Mosley T. H. Jr., Hutchinson R. G., Folsom A. R., Harris T. B. et al. Alcohol intake and cerebral ab- normalities on magnetic resonance imaging in a community-based population of middle-aged adults: the ath- erosclerosis risk in communities (ARIC) study. Stroke 2004; 35: 16-21.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_v3TEjDC">Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Ronksley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Mukamal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Ghali</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9NuAaNw">BMJ</title>
		<imprint>
			<biblScope unit="volume">342</biblScope>
			<biblScope unit="page">671</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ronksley P. E., Brien S. E., Turner B. J., Mukamal K. J., Ghali W. A. Association of alcohol consumption with selected car- diovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011; 342: d671.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_Yt697uB">Adherence to a Mediterranean diet is associated with the presence and extension of atherosclerotic plaques in middle-aged asymptomatic adults: the Aragon Workers&apos; health study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Mateo-Gallego</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Uzhova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Moreno-Franco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leon-Latre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Casasnovas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laclaustra</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacl.2017.08.007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qVEARtC">J Clin Lipidol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1372" to="1382" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mateo-Gallego R., Uzhova I., Moreno-Franco B., Leon-Latre M., Casasnovas J. A., Laclaustra M. et al. Adherence to a Mediterranean diet is associated with the presence and exten- sion of atherosclerotic plaques in middle-aged asymptomatic adults: the Aragon Workers&apos; health study. J Clin Lipidol 2017; 11: 1372-82; e4.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_g3AwDFe">Tobacco and alcohol consumption: impact on other cardiovascular and cancer risk factors in a southern European Mediterranean population</title>
		<author>
			<persName><forename type="first">H</forename><surname>Schroder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Marrugat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Elosua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Covas</surname></persName>
		</author>
		<idno type="DOI">10.1079/bjn2002655</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_apZsPQM">Br J Nutr</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="273" to="281" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schroder H., Marrugat J., Elosua R., Covas M. I. Tobacco and alcohol consumption: impact on other cardiovascular and cancer risk factors in a southern European Mediterranean population. Br J Nutr 2002; 88: 273-81.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_EfsMbtW">Influence of smoking on incidence and prevalence of peripheral arterial disease</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Willigendael</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Teijink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Bartelink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Kuiken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Boiten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Moll</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Q8BH3sj">J Vasc Surg</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1158" to="1165" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Willigendael E. M., Teijink J. A., Bartelink M. L., Kuiken B. W., Boiten J., Moll F. L. et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg 2004; 40: 1158-65.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_wy4KJw7">European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Piepoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Hoes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agewall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Albus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brotons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Catapano</surname></persName>
		</author>
		<idno type="DOI">10.1093/eurheartj/ehw106</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sRhmfjW">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="2315" to="2381" />
			<date type="published" when="2016">2016. 2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Piepoli M. F., Hoes A. W., Agewall S., Albus C., Brotons C., Catapano A. L. et al. 2016 European guidelines on cardiovas- cular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315-81.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_GrXkcbd">ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Goff</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Lloyd-Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Coady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>D'agostino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gibbons</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.cir.0000437741.48606.98</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XwAaMDu">Circulation</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="49" to="S73" />
			<date type="published" when="2013">2013. 2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goff D. C. Jr., Lloyd-Jones D. M., Bennett G., Coady S., D&apos;Agostino R. B., Gibbons R. et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2014; 129: S49-S73.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_5cnkwvq">Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Pryor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stone</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1749-6632.1993.tb39148.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DpQa27y">Ann NY Acad Sci</title>
		<imprint>
			<biblScope unit="volume">686</biblScope>
			<biblScope unit="page" from="27" to="28" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pryor W. A., Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann NY Acad Sci 1993; 686: 12-27; discussion 27-8.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_BjcCDP4">Contribution of red wine consumption to human health protection</title>
		<author>
			<persName><forename type="first">L</forename><surname>Snopek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mlcek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sochorova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hlavacova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Jurikova</surname></persName>
		</author>
		<idno type="DOI">10.3390/molecules23071684</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_u8Fq7Sk">Molecules</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">E1684</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Snopek L., Mlcek J., Sochorova L., Baron M., Hlavacova I., Jurikova T. et al. Contribution of red wine consumption to human health protection. Molecules 2018; 23: pii: E1684.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_cVpFFKV">Alcohol consumption and cardiovascular risk: mechanisms of action and epidemiologic perspectives</title>
		<author>
			<persName><forename type="first">Di</forename><surname>Castelnuovo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Costanzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Di Giuseppe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>De Gaetano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Iacoviello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
		<idno type="DOI">10.2217/fca.09.36</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tmNbrjw">Future Cardiol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="467" to="477" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Di Castelnuovo A., Costanzo S., di Giuseppe R., de Gaetano G., Iacoviello L. Alcohol consumption and cardiovascular risk: mechanisms of action and epidemiologic perspectives. Future Cardiol 2009; 5: 467-77.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_dJxWEhm">Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rotches-Ribalta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Andres-Lacueva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Estruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Escribano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Urpi-Sarda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jyxHCQW">Pharmacol Res</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="375" to="382" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rotches-Ribalta M., Andres-Lacueva C., Estruch R., Escribano E., Urpi-Sarda M. Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets. Pharmacol Res 2012; 66: 375-82.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_t38x7aY">Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Costanzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Castelnuovo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Donati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Iacoviello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>De Gaetano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_q787a7M">Eur J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="833" to="850" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Costanzo S., Di Castelnuovo A., Donati M. B., Iacoviello L., de Gaetano G. Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis. Eur J Epidemiol 2011; 26: 833-50.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_vJWkR4d">Alcohol consumption and outcome in stable outpatients with peripheral artery disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Garcia-Diaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Marchena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Toril</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Arnedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Munoz-Torrero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yeste</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gq9RShm">J Vasc Surg</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="1081" to="1087" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Garcia-Diaz A. M., Marchena P. J., Toril J., Arnedo G., Munoz- Torrero J. F., Yeste M. et al. Alcohol consumption and outcome in stable outpatients with peripheral artery disease. J Vasc Surg 2011; 54: 1081-7.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_kJzw5aJ">Alcohol consumption and ankle-to-brachial index: results from the cardiovascular risk survey</title>
		<author>
			<persName><forename type="first">X</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">T</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">N</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Huang</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0015181</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WdjFFdu">PLOS ONE</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">e15181</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Xie X., Ma Y. T., Yang Y. N., Li X. M., Liu F., Huang D. et al. Alcohol consumption and ankle-to-brachial index: results from the cardiovascular risk survey. PLOS ONE 2010; 5: e15181.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_yDe8Xup">A renaissance for measurement error</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Michels</surname></persName>
		</author>
		<idno type="DOI">10.1093/ije/30.3.421</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ebAXNNv">Int J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="421" to="422" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Michels K. B. A renaissance for measurement error. Int J Epidemiol 2001; 30: 421-2.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
